Exploration of pyrazole-based pyridine-4-carbohydrazide derivatives as drug-resistant <i>Mtb</i> agents: design, synthesis, biological evaluation, and <i>in-silico</i> studies
The pyrazole clubbed with pyridine-4-carbohydrazide is a potential scaffold for further exploration as anti-TB agent.
Authors
- Venkata Madhavi Yaddanapudi (ORCID: https://orcid.org/0000-0002-9813-8694)
- Sugali Indravath Rajyalakshmi
- Nagesh A. Bhale
- Deepanshi Saxena (ORCID: https://orcid.org/0000-0001-9785-6224)
- Amol G. Dikundwar (ORCID: https://orcid.org/0000-0002-7149-1279)
- Srinivas Nanduri (ORCID: https://orcid.org/0000-0002-6671-2022)
- Sidharth Chopra (ORCID: https://orcid.org/0000-0001-8823-6074)
- Pardeep Kumar (ORCID: https://orcid.org/0000-0001-8582-935X)
- Juned Ali
- Amitava Dasgupta (ORCID: https://orcid.org/0000-0001-9014-1904)
- Anuradha Singampalli (ORCID: https://orcid.org/0009-0004-1827-9131)
- Pradip Malik
- Rani Bandela
- Sri Mounika Bellapukonda
Institutions
- Central Drug Research Institute (IN)
- Academy of Scientific and Innovative Research (IN)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1080/17568919.2025.2525069
- Citations
- 4
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 5.58